{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute therapy for suspected inflammatory demyelination (NMOSD/MS) To accelerate recovery and minimise axonal damage\n\n*   **Treatment:** Prophylactic Enoxaparin\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Venous thromboembolism prophylaxis is indicated due to patient immobility and hospital admission\n\n*   **Treatment:** Plasma Exchange (PLEX)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Reserve as rescue therapy if there is no significant improvement with corticosteroids\n\n*   **Treatment:** Long-term Immunotherapy (e.g., Rituximab, Eculizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Selection of specific agent depends on definitive antibody status (AQP4 vs MOG vs Seronegative)\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute therapy for suspected inflammatory demyelination (NMOSD/MS)\", \"To accelerate recovery and minimise axonal damage\"]}, {\"treatment\": \"Prophylactic Enoxaparin\", \"timing\": \"Start Now\", \"reasons\": [\"Venous thromboembolism prophylaxis is indicated due to patient immobility and hospital admission\"]}, {\"treatment\": \"Plasma Exchange (PLEX)\", \"timing\": \"Delay\", \"reasons\": [\"Reserve as rescue therapy if there is no significant improvement with corticosteroids\"]}, {\"treatment\": \"Long-term Immunotherapy (e.g., Rituximab, Eculizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Selection of specific agent depends on definitive antibody status (AQP4 vs MOG vs Seronegative)\"]}]"
}